923 / 1241
Hartenbach et al. Clin Cancer Res., 2014
Modality
Sens (%) Spec (%) PPV (%) NPV (%) Acc (%)
MR (T2)
67
35
59
44
54
PET
(18F-Chol)
85
45
68
69
68
PET/MR
84
80
85
78
82
N=98 Lesions >5 mm
PET/MRI – Primary Prostate Cancer